glp-1+nad Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) EllieMD | GLP-1/NAD+ Oral Drops
Description
Source quality matters
Rosenstock J, Frias J, Jastreboff AM, Du Y, Lou J, Gurbuz S, Thomas MK, Hartman ML, Haupt A, Milicevic Z, et al
People lost 14 percent of their body weight on average with the Wegovy pill and an average of 15 percent on the Wegovy injection. Dr
Ozempic and Mounjaro are covered for type 2 diabetes across all Humana MA plans, with the same PA criteria as Part D
Ulie, 2025)
If that happens, it may be worth considering some of the other medications approved for weight loss that are not GLP-1s
